Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Cysteamine

EU orphan designation number: EU/3/11/928   
Active ingredient: Cysteamine
Indication: Treatment of cystic fibrosis
Sponsor: NovaBiotics Ltd
Cruickshank Building, Craibstone, Aberdeen AB21 9TR, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/12/2011 Centralised Orphan - Designation EMA/OD/046/11 (2011)9412 of 09/12/2011